Page last updated: 2024-12-11

sucrose monolaurate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

sucrose monolaurate: RN given refers to monolaurate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9898326
CHEMBL ID4060183
SCHEMBL ID33581
MeSH IDM0069427

Synonyms (27)

Synonym
dodecanoyl-d-sucrose
sucrose monolaurate, bioxtra, >=97.0% (tlc)
sucrose monolaurate
sucrose, 6-laurate
2an420ds8i ,
unii-2an420ds8i
13039-40-2
SCHEMBL33581
.alpha.-d-glucopyranoside, .beta.-d-fructofuranosyl, 6-dodecanoate
6-dodecanoyl-.alpha.-d-glucopyranoside, .beta.-d-fructofuranosyl
sucrosemonolaurate
W-202067
mfcd00077947
DTXSID90156500
AKOS030529188
((2r,3s,4s,5r,6r)-6-(((2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)methyl dodecanoate
F10806
KGUHOFWIXKIURA-VQXBOQCVSA-N
AS-46880
((2r,3s,4s,5r,6r)-6-((2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yloxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)methyl dodecanoate
A12345
CHEMBL4060183
[(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl dodecanoate
Q27254485
6-lauratesucrose
A877619
((2r,3s,4s,5r,6r)-6-(((2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)methyl dodecanoate;surfhope se cosme c 1216; surfhope se pharma d 1216; sucrose lauric acid monoester

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"The effects of sucrose esters of fatty acids, alone and in combination with ethylenediaminetetraacetic acid (EDTA), acetic acid, lactic acid and citric acid, on survival, growth and thermal inactivation of Listeria monocytogenes and Staphylococcus aureus were determined."( Inhibitory effects of sucrose monolaurate, alone and in combination with organic acids, on Listeria monocytogenes and Staphylococcus aureus.
Beuchat, LR; Hathcox, AK; Monk, JD, 1996
)
0.29

Bioavailability

ExcerptReferenceRelevance
" Using rabbits as an animal model, the absolute bioavailability and the skin irritation were evaluated after single and multiple application."( Sucrose laurate gels as a percutaneous delivery system for oestradiol in rabbits.
De Muynck, C; Eechaute, W; Geerts, ML; Remon, JP; Vandenbossche, G; Vermeire, A, 1996
)
0.29
" According to the latest examinations, the bioavailability of poorly water soluble drugs can be increased significantly by using surfactants or the mixture of surfactants and polymers."( [The applicability of sucrose laurate in hot-melt technology].
Ambrus, R; Lang, P; Szabóné, RP; Szuts, A, 2011
)
0.37
"Low water-soluble SEs exhibited slight and/or slow absorption enhancement effects, while L-1695, being highly water-soluble, had good potential to enhance the absorption rate and extent."( Enhancement potential of sucrose laurate (L-1695) on intestinal absorption of water-soluble high molecular weight compounds.
Imura, Y; Machida, Y; Onishi, H; Uchida, M, 2012
)
0.38
" The NS showed much higher dissolution rate, cytotoxicity and bioavailability when compared with the free drug."( Development and evaluation of optimized sucrose ester stabilized oleanolic acid nanosuspensions prepared by wet ball milling with design of experiments.
Heng, PW; Li, W; Ng, KY, 2014
)
0.4
"The present study was carried out to develop an oral formulation of pranlukast hemihydrate with improved dissolution and oral bioavailability using a surface-modified microparticle."( Improving dissolution and oral bioavailability of pranlukast hemihydrate by particle surface modification with surfactants and homogenization.
Baek, IH; Ha, ES; Jung, Y; Kim, MS; Yoo, JW, 2015
)
0.42
" A problem is that the (in-vivo) rate of absorption cannot be directly measured and for that reason, it is frequently substituted by evaluation of the (in-vitro) dissolution."( In-Vivo Analysis and Model-Based Prediction of Tensides' Influence on Drug Absorption.
Babinec, A; Murgaš, J; Pavlovičová, J; Tárník, M; Vitko, A; Vitková, Z, 2021
)
0.62
" Thus, we have developed a method of retaining high dissolution rate and, by implication, high bioavailability of nanocrystals from solid formulations."( Development of Fully Redispersible Dried Nanocrystals by Using Sucrose Laurate as Stabilizer for Increasing Surface Area and Dissolution Rate of Poorly Water-Soluble Drugs.
Prajapati, H; Serajuddin, ATM, 2022
)
0.72

Dosage Studied

ExcerptRelevanceReference
" In addition, the enhancement effect after dosing into the different small intestinal regions, the effect on FDs with different MWs and the influence of N-acetyl-cysteine (NAC) co-existence were examined."( Enhancement potential of sucrose laurate (L-1695) on intestinal absorption of water-soluble high molecular weight compounds.
Imura, Y; Machida, Y; Onishi, H; Uchida, M, 2012
)
0.38
"Depending on their concentrations the surface-active substances, tensides (surfactants) can positively or negatively influence the drug absorption, which is widely used in the design of the dosage forms with controlled release."( In-Vivo Analysis and Model-Based Prediction of Tensides' Influence on Drug Absorption.
Babinec, A; Murgaš, J; Pavlovičová, J; Tárník, M; Vitko, A; Vitková, Z, 2021
)
0.62
" However, nanocrystals are prepared as aqueous suspensions, and once the suspensions are dried for development of solid dosage forms, the nanocrystals agglomerate as large particles to reduce the excess surface energy."( Development of Fully Redispersible Dried Nanocrystals by Using Sucrose Laurate as Stabilizer for Increasing Surface Area and Dissolution Rate of Poorly Water-Soluble Drugs.
Prajapati, H; Serajuddin, ATM, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1438600Surfactant property of the compound in aqueous solution assessed as critical micelle concentration or minimal hydrotropic concentration2017European journal of medicinal chemistry, Mar-10, Volume: 128Synthesis, surfactant properties and antimicrobial activities of methyl glycopyranoside ethers.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (69)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (7.25)18.7374
1990's12 (17.39)18.2507
2000's11 (15.94)29.6817
2010's35 (50.72)24.3611
2020's6 (8.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.41%)5.53%
Reviews1 (1.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other69 (97.18%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]